At Loxo Oncology, we are focused on developing treatments for people with cancers that are caused by a single inappropriate DNA change, known as an “oncogenic driver.” Our work focuses on these single gene abnormalities, such that one medicine could have the potential to treat the cancer with dramatic effect. To the greatest extent possible, we are working to design highly selective medicines because we believe drugs built...
At Loxo Oncology, we are focused on developing treatments for people with cancers that are caused by a single inappropriate DNA change, known as an “oncogenic driver.” Our work focuses on these single gene abnormalities, such that one medicine could have the potential to treat the cancer with dramatic effect. To the greatest extent possible, we are working to design highly selective medicines because we believe drugs built with a single purpose have the highest probability of deeply inhibiting the affected pathway.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.